NasdaqGM - Nasdaq Real Time Price USD

RxSight, Inc. (RXST)

Compare
37.58 -1.59 (-4.06%)
At close: December 11 at 4:00:00 PM EST
39.00 +1.42 (+3.78%)
Pre-Market: 5:04:18 AM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
128,293.00
89,077.00
49,005.00
22,593.00
14,678.00
Cost of Revenue
40,484.00
35,312.00
27,677.00
18,076.00
12,973.00
Gross Profit
87,809.00
53,765.00
21,328.00
4,517.00
1,705.00
Operating Expense
126,891.00
103,850.00
84,646.00
57,304.00
37,110.00
Operating Income
-39,082.00
-50,085.00
-63,318.00
-52,787.00
-35,405.00
Net Non Operating Interest Income Expense
8,408.00
3,266.00
-3,429.00
-3,628.00
33.00
Other Income Expense
--
-1,769.00
--
7,735.00
63,004.00
Pretax Income
-30,674.00
-48,588.00
-66,747.00
-48,680.00
27,632.00
Tax Provision
20.00
20.00
9.00
8.00
57.00
Net Income Common Stockholders
-30,694.00
-48,608.00
-66,756.00
-48,688.00
3,366.00
Diluted NI Available to Com Stockholders
-30,694.00
-48,608.00
-66,756.00
-48,688.00
3,366.00
Basic EPS
-0.81
-1.41
-2.41
-3.57
0.18
Diluted EPS
-0.81
-1.41
-2.41
-3.57
0.18
Basic Average Shares
37,770.43
34,455.11
27,661.98
13,625.04
19,073.11
Diluted Average Shares
37,770.43
34,455.11
27,661.98
13,625.04
19,073.11
Total Operating Income as Reported
-39,082.00
-50,085.00
-63,318.00
-52,787.00
-35,412.00
Total Expenses
167,375.00
139,162.00
112,323.00
75,380.00
50,083.00
Net Income from Continuing & Discontinued Operation
-30,694.00
-48,608.00
-66,756.00
-48,688.00
27,575.00
Normalized Income
-30,694.00
-46,839.00
-66,756.00
-56,423.00
-35,299.03
Interest Income
8,428.00
6,574.00
1,517.00
54.00
543.00
Interest Expense
20.00
3,308.00
4,946.00
3,682.00
510.00
Net Interest Income
8,408.00
3,266.00
-3,429.00
-3,628.00
33.00
EBIT
-30,654.00
-45,280.00
-61,801.00
-44,998.00
28,142.00
EBITDA
-26,469.00
-41,037.00
-57,779.00
-41,010.00
32,154.00
Reconciled Cost of Revenue
40,484.00
35,312.00
27,677.00
18,076.00
12,973.00
Reconciled Depreciation
4,185.00
4,243.00
4,022.00
3,988.00
4,012.00
Net Income from Continuing Operation Net Minority Interest
-30,694.00
-48,608.00
-66,756.00
-48,688.00
27,575.00
Total Unusual Items Excluding Goodwill
--
-1,769.00
--
7,735.00
63,004.00
Total Unusual Items
--
-1,769.00
--
7,735.00
63,004.00
Normalized EBITDA
-26,469.00
-39,268.00
-57,779.00
-48,745.00
-30,850.00
Tax Rate for Calcs
0.00
--
--
--
0.00
Tax Effect of Unusual Items
--
--
--
--
129.97
12/31/2020 - 7/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SGHT Sight Sciences, Inc.
3.9000
-0.26%
 
GKOS Glaukos Corporation
142.89
+4.77%
 
NARI Inari Medical, Inc.
58.21
+5.74%
 
PRCT PROCEPT BioRobotics Corporation
90.61
-0.61%
 
LNSR LENSAR, Inc.
7.64
+0.92%
 
INSP Inspire Medical Systems, Inc.
192.77
+1.77%
 
OFIX Orthofix Medical Inc.
18.54
-0.05%
 
RPID Rapid Micro Biosystems, Inc.
1.0100
-2.88%
 
UFPT UFP Technologies, Inc.
295.60
+1.68%
 
OM Outset Medical, Inc.
1.2300
-4.65%